Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

M.T.E.-4 CONCENTRATED 10 MCG

CHROMIUM (CHROMIC CHLORIDE) : 10 MCG ZINC (ZINC SULFATE) : 5 MG MANGANESE (MANGANESE SULFATE) : 0.5 MG COPPER (CUPRIC SULFATE) : 1 MG · DIN 02139251 · PHARMACEUTICAL PARTNERS OF CANADA INC

Health Canada status: CANCELLED POST MARKET

What is M.T.E.-4 CONCENTRATED?

M.T.E.-4 CONCENTRATED 10 MCG contains CHROMIUM (CHROMIC CHLORIDE) : 10 MCG ZINC (ZINC SULFATE) : 5 MG MANGANESE (MANGANESE SULFATE) : 0.5 MG COPPER (CUPRIC SULFATE) : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02139251, held by PHARMACEUTICAL PARTNERS OF CANADA INC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 15-Feb-2008. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02139251
Brand nameM.T.E.-4 CONCENTRATED
Generic / active ingredientCHROMIUM (CHROMIC CHLORIDE) : 10 MCG ZINC (ZINC SULFATE) : 5 MG MANGANESE (MANGANESE SULFATE) : 0.5 MG COPPER (CUPRIC SULFATE) : 1 MG
ManufacturerPHARMACEUTICAL PARTNERS OF CANADA INC
Strength10 MCG
Dosage formSOLUTION
Route of administrationINTRAVENOUS
ScheduleEthical
ATC codeB05XA30 COMBINATIONS OF ELECTROLYTES
AHFS class40:12.00
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date15-Feb-2008
Original market date1987-12-30 00:00:00

What can be used instead?

Other Canadian products sharing ATC code B05XA30 COMBINATIONS OF ELECTROLYTES. 1 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
TPN ELECTROLYTES16.55 MGSOLUTIONPFIZER CANADA ULCMARKETEDDIN 00590215
CARBICARB INJECTION35 MGLIQUIDINTERNATIONAL MEDICATION SYSTEMS LTD.CANCELLED POST MARKETDIN 00757004
HYPERLYTE (MULTI-ELECTROLYTE CONCENTRATE)690 MG / 25 MLLIQUIDB. BRAUN MEDICAL INCCANCELLED POST MARKETDIN 01963910
LYPHOLYTE2.5 G / 20 MLSOLUTIONPHARMACEUTICAL PARTNERS OF CANADA INCCANCELLED POST MARKETDIN 02139618
LYPHOLYTE MULTI-ELECTROLYTE CONC INJ43 MGLIQUIDLYPHOMED, DIVISION OF FUJISAWA CANADA INC.CANCELLED POST MARKETDIN 01944940
M.T.E.-41 MGSOLUTIONPHARMACEUTICAL PARTNERS OF CANADA INCCANCELLED POST MARKETDIN 02139278
M.T.E.-6 CONCENTRATED5 MGSOLUTIONPHARMACEUTICAL PARTNERS OF CANADA INCCANCELLED POST MARKETDIN 02139235
MTE 4 INJ1 MGLIQUIDLYPHOMED, DIVISION OF FUJISAWA CANADA INC.CANCELLED POST MARKETDIN 01945319
MULTIPLE ELECTROLYTE ADDITIVE INJ29.8 MGLIQUIDINTERNATIONAL MEDICATION SYSTEMS LTD.CANCELLED POST MARKETDIN 00421952

Who else supplies COMBINATIONS OF ELECTROLYTES worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. COMBINATIONS OF ELECTROLYTES appears in 5 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02139251. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.